Mary Dunn

1.6k total citations
25 papers, 1.1k citations indexed

About

Mary Dunn is a scholar working on Oncology, Surgery and Immunology. According to data from OpenAlex, Mary Dunn has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Surgery and 8 papers in Immunology. Recurrent topics in Mary Dunn's work include Immunotherapy and Immune Responses (8 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Mary Dunn is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Mary Dunn collaborates with scholars based in United States, Switzerland and Spain. Mary Dunn's co-authors include Scott Antonia, Mayer Fishman, Dmitry I. Gabrilovich, Ingo Fricke, Noweeda Mirza, Anthony Neuger, Richard M. Lush, Meredith Wallace Kazer, Allison M. Deal and Matthew E. Nielsen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Mary Dunn

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Dunn United States 14 531 519 200 149 143 25 1.1k
Andrew Jacobs United States 17 265 0.5× 485 0.9× 160 0.8× 217 1.5× 229 1.6× 29 1.2k
Linda Van Le United States 14 269 0.5× 367 0.7× 302 1.5× 82 0.6× 181 1.3× 30 1.2k
Timothy Clay Australia 18 464 0.9× 637 1.2× 309 1.5× 177 1.2× 81 0.6× 84 1.2k
Fuat Oduncu Germany 23 430 0.8× 643 1.2× 576 2.9× 62 0.4× 72 0.5× 74 1.5k
Juergen Wolf Germany 20 239 0.5× 610 1.2× 324 1.6× 324 2.2× 43 0.3× 58 1.3k
Michael Sebastian Germany 20 360 0.7× 330 0.6× 137 0.7× 382 2.6× 79 0.6× 57 1.4k
Jan Schmielau Germany 9 674 1.3× 435 0.8× 202 1.0× 49 0.3× 49 0.3× 16 1.0k
Zhen Ni Zhou United States 13 490 0.9× 398 0.8× 172 0.9× 84 0.6× 54 0.4× 27 996
Sylvie Martel France 19 164 0.3× 197 0.4× 580 2.9× 59 0.4× 125 0.9× 31 1.1k
Nicole Schmidt Germany 16 283 0.5× 126 0.2× 307 1.5× 60 0.4× 196 1.4× 26 927

Countries citing papers authored by Mary Dunn

Since Specialization
Citations

This map shows the geographic impact of Mary Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Dunn more than expected).

Fields of papers citing papers by Mary Dunn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Dunn. The network helps show where Mary Dunn may publish in the future.

Co-authorship network of co-authors of Mary Dunn

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Dunn. A scholar is included among the top collaborators of Mary Dunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Dunn. Mary Dunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bortiri, Esteban, Rachel L. Egger, Shujie Dong, et al.. (2024). Cyto-swapping in maize by haploid induction with a cenh3 mutant. Nature Plants. 10(4). 567–571. 12 indexed citations
2.
Dunn, Mary, Amir H. Khandani, Paul A. Godley, et al.. (2021). A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer. PLoS ONE. 16(6). e0253021–e0253021. 5 indexed citations
3.
Goltz, Heather Honoré, et al.. (2021). Collaboration Between Oncology Social Workers and Nurses: A Patient-Centered Interdisciplinary Model of Bladder Cancer Care. Seminars in Oncology Nursing. 37(1). 151114–151114. 10 indexed citations
4.
Rose, Tracy L., Michael R. Harrison, Allison M. Deal, et al.. (2021). Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer. Journal of Clinical Oncology. 39(28). 3140–3148. 93 indexed citations
5.
Chang, Hao, Patricia Kinneer, Mary Dunn, et al.. (2020). Improving Couples’ Quality of Life Through 
a Web-Based Prostate Cancer Education Intervention. UNC Libraries. 1 indexed citations
6.
Rose, Tracy L., David D. Chism, Ajjai Alva, et al.. (2018). Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy. British Journal of Cancer. 119(7). 801–807. 28 indexed citations
7.
Quinn, M., et al.. (2018). Decision-making surrounding the use of preimplantation genetic testing for aneuploidy reveals misunderstanding regarding its benefit. Fertility and Sterility. 110(4). e406–e406. 3 indexed citations
8.
Dunn, Mary. (2017). Prostate Cancer Screening. Seminars in Oncology Nursing. 33(2). 156–164. 21 indexed citations
9.
Song, Lixin, Christine Rini, Allison M. Deal, et al.. (2015). Improving Couples’ Quality of Life Through 
a Web-Based Prostate Cancer Education Intervention. Oncology nursing forum. 42(2). 183–192. 58 indexed citations
10.
Rose, Tracy L., Allison M. Deal, Ethan Basch, et al.. (2015). Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings. Urologic Oncology Seminars and Original Investigations. 33(9). 386.e1–386.e6. 13 indexed citations
11.
Dunn, Mary. (2015). Bladder Cancer: A Focus on Sexuality. Clinical journal of oncology nursing. 19(1). 68–73. 6 indexed citations
12.
Finkelstein, Steven E., Francisco R. Rodriguez, Mary Dunn, et al.. (2012). Serial Assessment of Lymphocytes and Apoptosis in the Prostate During Coordinated Intraprostatic Dendritic Cell Injection and Radiotherapy. Immunotherapy. 4(4). 373–382. 34 indexed citations
13.
Dunn, Mary & Meredith Wallace Kazer. (2011). Prostate Cancer Overview. Seminars in Oncology Nursing. 27(4). 241–250. 93 indexed citations
14.
Finkelstein, Steven E., Timothy S. Carey, Ingo Fricke, et al.. (2010). Changes in Dendritic Cell Phenotype After a New High-dose Weekly Schedule of Interleukin-2 Therapy for Kidney Cancer and Melanoma. Journal of Immunotherapy. 33(8). 817–827. 31 indexed citations
15.
Fishman, Mayer, Terri Hunter, Hatem Soliman, et al.. (2008). Phase II Trial of B7-1 (CD-86) Transduced, Cultured Autologous Tumor Cell Vaccine Plus Subcutaneous Interleukin-2 for Treatment of Stage IV Renal Cell Carcinoma. Journal of Immunotherapy. 31(1). 72–80. 52 indexed citations
16.
17.
Mirza, Noweeda, Mayer Fishman, Ingo Fricke, et al.. (2006). All-trans-Retinoic Acid Improves Differentiation of Myeloid Cells and Immune Response in Cancer Patients. Cancer Research. 66(18). 9299–9307. 443 indexed citations
18.
Thompson, Patricia A., Mayer Fishman, John D. Seigne, et al.. (2005). Phase II study of B7–1 gene-modified autologous tumor cell vaccine and subcutaneous IL-2 for patients with stage IV renal cell carcinoma (RCC). Journal of Clinical Oncology. 23(16_suppl). 4502–4502. 2 indexed citations
19.
20.
Mukai, Noritsugu, Takashi Nakajima, Thomas F. Freddo, Margaretha Jacobson, & Mary Dunn. (1977). Retinoblastoma-like neoplasm induced in C3H/BifB/Ki strain mice by human adenovirus serotype 12. Acta Neuropathologica. 39(2). 147–155. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Jacobs Breakdown of academic impact, for papers by Linda Van Le Breakdown of academic impact, for papers by Timothy Clay Breakdown of academic impact, for papers by Fuat Oduncu Breakdown of academic impact, for papers by Juergen Wolf Breakdown of academic impact, for papers by Michael Sebastian Breakdown of academic impact, for papers by Jan Schmielau Breakdown of academic impact, for papers by Zhen Ni Zhou Breakdown of academic impact, for papers by Sylvie Martel Breakdown of academic impact, for papers by Nicole Schmidt
Rankless by CCL
2026